
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience
What it is
A panel with four Compass Pathways research scientists explores the company’s Oxford clinical research into psychedelics as a treatment for depression.
The panel explores Compass Pathways’ clinical research in Oxford into psychedelics as a treatment for depression.
The Oxford Psychedelic and Psychology Societies host four research scientists from Compass Pathways.
The event is in person on Thursday 19 November 2026, from 19:30 to 21:00.
Questions
When does Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience start and end?
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience runs Thursday, 19 November 2026, 19:30 until 21:00.
Where is Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience?
Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience takes place at New College, Holywell Street, McGregor Matthews Room Oxford, Oxford.
How much are tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience?
Tickets for Guy Goodwin and Compass Pathways: Remedicalising the Psychedelic Experience cost £3.96 on the official ticket shop.
How do I book?
Book through **Eventbrite**: https://www.eventbrite.co.uk/e/guy-goodwin-and-compass-pathways-remedicalising-the-psychedelic-experience-tickets-2003092642014
What is the panel about?
It explores Compass Pathways’ clinical research in Oxford into psychedelics as a treatment for depression. **COMP360** is the company’s lead synthetic psilocybin compound and is currently undergoing **FDA review**.










